Jan-Erik Fr�din

Immunohistochemical monitoring of metastatic colorectal carcinoma in patients treated with monoclonal antibodies (MAb 17-1A)

J. Shetye, Jan-Erik Fr�din, Birger Christensson et al. · Cancer Immunology Immunotherapy · 1988 · 59 citations · Full text

Medicine, Oncology, Pathology +17

Granulocyte/macrophage-colony-stimulating factor augments the induction of antibodies, especially anti-idiotypic antibodies, to therapeutic monoclonal antibodies

Peter Ragnhammar, Jan Fagerberg, Jan-Erik Fr�din et al. · Cancer Immunology Immunotherapy · 1995 · 25 citations · Full text

Pharmacy, Immunology, Pharmacology +11

Functional HLA-DR T cell epitopes of CEA identified in patients with colorectal carcinoma immunized with the recombinant protein CEA

Gustav Ullenhag, H�kan Mellstedt, Jan Fagerberg et al. · Cancer Immunology Immunotherapy · 2004 · 11 citations · Full text

Life Sciences, Immunology, Oncology +16

T-cell receptor BV gene usage in colorectal carcinoma patients immunised with recombinant Ep-CAM protein or anti-idiotypic antibody

Szilvia Mosolits, Katja Markovic, Jan Fagerberg et al. · Cancer Immunology Immunotherapy · 2004 · 10 citations · Full text

Life Sciences, Immunology, Oncology +17